SMV pursues high-energy imaging

Article

Like many other nuclear medicine vendors, SMV of Twinsburg, OH,is developing high-energy imaging technologies to image fluorodeoxyglucose,the radiotracer used in most PET studies. At its RSNA booth, SMVwill display both collimated and coincidence

Like many other nuclear medicine vendors, SMV of Twinsburg, OH,is developing high-energy imaging technologies to image fluorodeoxyglucose,the radiotracer used in most PET studies. At its RSNA booth, SMVwill display both collimated and coincidence detection-based high-energymethods, according to Robert Ripley, director of corporate communications.

SMV will also debut a new motion-correction program designedto work with its Transmission Attenuation Correction (TAC) productand its Restore resolution recovery algorithm.

Recent Videos
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Nina Kottler, MD, MS
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2025 MJH Life Sciences

All rights reserved.